Pulmonary Hypertension and Venous Thromboembolism http://www.acc.org/Feed?clinicalTopicID=9cb8eff7-d78e-4dfc-a992-2905830cc91f Clinical Topic Feed: Pulmonary Hypertension and Venous Thromboembolism en Eagle’s Eye View: Can Sugar-Sweetened Beverages and Fruit Juice Lead to Hypertension? /Latest-in-Cardiology/Articles/2026/07/08/14/16/eagles-eye-view-08jul2026 In this week’s View, Dr. Eagle looks at withdrawing guideline-directed medical therapy (GDMT) for patients with atrial fibrillation (AF). 1783520220000 Articles and Stories ACC Featured Jobs For July 2026 /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1782902880000 Articles and Stories ACC Scientific Statement Addresses DOACs in Primary and Secondary Prevention of Thrombotic Events /Latest-in-Cardiology/Journal-Scans/2026/06/29/15/38/ACC-Scientific-Statement-Addresses-DOACs Even with robust evidence demonstrating their efficacy and safety, direct oral anticoagulants (DOACs) continue to be underused and, at times, inappropriately dosed, particularly in patients at elevated thrombotic risk. 1782828120000 Articles and Stories New Risk Score Helps Identify Bleeding Risk With DOACs in Cancer-Associated VTE /Latest-in-Cardiology/Journal-Scans/2026/06/24/22/05/New-Risk-Score The novel ONCO-DOAC BLEED risk score, developed by Tomoyuki Nagai, MD, et al., provided clinically relevant major bleeding risk stratification for patients with cancer-associated venous thromboembolism (VTE) receiving direct oral anticoagulants (DOAC), according to research published June 16 in JACC: CardioOncology. 1782407460000 Articles and Stories ACCEL Lite: Insights From the CADENCE Trial /Latest-in-Cardiology/Articles/2026/06/02/12/49/accel-lite-02jun2026 In this interview, Clyde W. Yancy MD, MACC and Mardi Gomberg-Maitland, MD, MSc, FACC discuss the CADENCE Trial (Efficacy And Safety Of Sotatercept In Combined Post-and Pre-capillary Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction). 1780414200000 Articles and Stories  Eagle’s Eye View: PCI Vs. CABG In Patients With Unprotected Left Main CAD: NOBLE Study /Latest-in-Cardiology/Articles/2026/05/06/13/43/eagles-eye-view-06may2026 In this week’s View, Dr. Eagle looks at the NOBLE trial evaluating whether percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is best for patients with unprotected left main coronary artery disease (CAD). 1778075040000 Articles and Stories Journal Wrap | Evolocumab Cuts Risk in Absence of ASCVD: Sotatercept For CpCPH, HFpEF /Latest-in-Cardiology/Articles/2026/05/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1777637340000 Articles and Stories Eagle’s Eye View: Can Cardiorespiratory Fitness Lead to Longer Lifespans? /Latest-in-Cardiology/Articles/2026/04/29/14/55/eagles-eye-view-29apr2026 In this week’s View, Dr. Eagle looks at endovascular therapy for post-thrombotic syndrome and how it reduces severity and improves quality of life. 1777474620000 Articles and Stories Heart Failure Trials Featured at ACC.26 /Latest-in-Cardiology/Articles/2026/04/27/19/07/Heart-Failure-Trials-Featured-at-ACC26 ACC.26 featured several late-breaking heart failure clinical trials, including two focused on subgroups of heart failure that until now had limited data to guide therapies. 1777460220000 Articles and Stories Current Evidence and Strategies to Address Sex Hormone-Associated Thrombotic and CV Risk /Latest-in-Cardiology/Journal-Scans/2026/04/21/16/07/Current-Evidence-and-Strategies The influences of sex hormone therapy – for contraception, treatment of heavy menstrual bleeding, hormone-replacement therapy, gender-affirming care therapy, etc. – on venous thrombotic and cardiovascular risk was explored in a Review Article published April 15 in NEJM. 1776793020000 Articles and Stories